Literature DB >> 20058312

The c-Rel subunit of nuclear factor-kappaB regulates murine liver inflammation, wound-healing, and hepatocyte proliferation.

Roben G Gieling1, Ahmed M Elsharkawy, Jorge H Caamaño, David E Cowie, Matthew C Wright, Mohammad R Ebrahimkhani, Alastair D Burt, Jelena Mann, Pradip Raychaudhuri, Hsiou-Chi Liou, Fiona Oakley, Derek A Mann.   

Abstract

UNLABELLED: In this study, we determined the role of the nuclear factor-kappaB (NF-kappaB) subunit c-Rel in liver injury and regeneration. In response to toxic injury of the liver, c-Rel null (c-rel(-/-)) mice displayed a defect in the neutrophilic inflammatory response, associated with impaired induction of RANTES (Regulated upon Activation, Normal T-cell Expressed, and Secreted; also known as CCL5). The subsequent fibrogenic/wound-healing response to both chronic carbon tetrachloride and bile duct ligation induced injury was also impaired and this was associated with deficiencies in the expression of fibrogenic genes, collagen I and alpha-smooth muscle actin, by hepatic stellate cells. We additionally report that c-Rel is required for the normal proliferative regeneration of hepatocytes in response to toxic injury and partial hepatectomy. Absence of c-Rel was associated with blunted and delayed induction of forkhead box M1 (FoxM1) and its downstream targets cyclin B1 and Cdc25C. Furthermore, isolated c-rel(-/-) hepatocytes expressed reduced levels of FoxM1 and a reduced rate of basal and epidermal growth factor-induced DNA synthesis. Chromatin immunoprecipitation revealed that c-Rel binding to the FoxM1 promoter is induced in the regenerating liver.
CONCLUSION: c-Rel has multiple functions in the control of liver homeostasis and regeneration and is a transcriptional regulator of FoxM1 and compensatory hepatocyte proliferation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20058312     DOI: 10.1002/hep.23385

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  25 in total

1.  c-Rel downregulation affects cell cycle progression of human keratinocytes.

Authors:  Verena N Lorenz; Michael P Schön; Cornelia S Seitz
Journal:  J Invest Dermatol       Date:  2013-07-26       Impact factor: 8.551

Review 2.  Hepatic inflammation and fibrosis: functional links and key pathways.

Authors:  Ekihiro Seki; Robert F Schwabe
Journal:  Hepatology       Date:  2015-01-28       Impact factor: 17.425

3.  The c-Rel Transcription Factor in Development and Disease.

Authors:  Thomas D Gilmore; Steve Gerondakis
Journal:  Genes Cancer       Date:  2011-07

Review 4.  NF-κB in the liver--linking injury, fibrosis and hepatocellular carcinoma.

Authors:  Tom Luedde; Robert F Schwabe
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-02       Impact factor: 46.802

5.  Dysregulated expression of FOXM1 isoforms drives progression of pancreatic cancer.

Authors:  Xiangyu Kong; Lei Li; Zhaoshen Li; Xiangdong Le; Chen Huang; Zhiliang Jia; Jiujie Cui; Suyun Huang; Liwei Wang; Keping Xie
Journal:  Cancer Res       Date:  2013-04-18       Impact factor: 12.701

6.  Classical and alternative activation of rat hepatic sinusoidal endothelial cells by inflammatory stimuli.

Authors:  Yinglin Liu; Carol R Gardner; Jeffrey D Laskin; Debra L Laskin
Journal:  Exp Mol Pathol       Date:  2012-10-24       Impact factor: 3.362

7.  The c-Rel subunit of NF-κB regulates epidermal homeostasis and promotes skin fibrosis in mice.

Authors:  Nicola Fullard; Anna Moles; Steven O'Reilly; Jacob M van Laar; David Faini; Julie Diboll; Nick J Reynolds; Derek A Mann; Julia Reichelt; Fiona Oakley
Journal:  Am J Pathol       Date:  2013-04-04       Impact factor: 4.307

8.  Scleroderma keratinocytes promote fibroblast activation independent of transforming growth factor beta.

Authors:  Sara S McCoy; Tamra J Reed; Celine C Berthier; Pei-Suen Tsou; Jianhua Liu; Johann E Gudjonsson; Dinesh Khanna; J Michelle Kahlenberg
Journal:  Rheumatology (Oxford)       Date:  2017-11-01       Impact factor: 7.580

9.  Stimulating healthy tissue regeneration by targeting the 5-HT₂B receptor in chronic liver disease.

Authors:  Mohammad R Ebrahimkhani; Fiona Oakley; Lindsay B Murphy; Jelena Mann; Anna Moles; Maria J Perugorria; Elizabeth Ellis; Anne F Lakey; Alastair D Burt; Angela Douglass; Matthew C Wright; Steven A White; Fabrice Jaffré; Luc Maroteaux; Derek A Mann
Journal:  Nat Med       Date:  2011-11-27       Impact factor: 53.440

10.  Ubiquitin C-terminal hydrolase 1: A novel functional marker for liver myofibroblasts and a therapeutic target in chronic liver disease.

Authors:  Caroline L Wilson; Lindsay B Murphy; Jack Leslie; Stuart Kendrick; Jeremy French; Christopher R Fox; Neil S Sheerin; Andrew Fisher; John H Robinson; Dina G Tiniakos; Douglas A Gray; Fiona Oakley; Derek A Mann
Journal:  J Hepatol       Date:  2015-08-08       Impact factor: 25.083

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.